Pediatrix Medical Group, Inc.
MD
$14.93
$0.050.34%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 458.36M | 502.36M | 511.16M | 504.30M | 495.10M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 458.36M | 502.36M | 511.16M | 504.30M | 495.10M |
| Cost of Revenue | 355.72M | 373.84M | 394.34M | 390.18M | 400.22M |
| Gross Profit | 102.64M | 128.53M | 116.82M | 114.12M | 94.88M |
| SG&A Expenses | 58.60M | 63.55M | 58.12M | 56.57M | 60.20M |
| Depreciation & Amortization | 5.33M | 6.87M | 6.25M | 8.79M | 10.31M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 419.65M | 444.26M | 458.71M | 455.53M | 470.73M |
| Operating Income | 38.71M | 58.10M | 52.45M | 48.76M | 24.37M |
| Income Before Tax | 28.09M | 33.33M | 25.24M | -167.73M | 7.82M |
| Income Tax Expenses | 7.35M | 2.85M | 5.79M | -14.70M | 3.79M |
| Earnings from Continuing Operations | 20.74M | 30.48M | 19.44M | -153.03M | 4.04M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 20.74M | 30.48M | 19.44M | -153.03M | 4.04M |
| EBIT | 38.71M | 58.10M | 52.45M | 48.76M | 24.37M |
| EBITDA | 44.04M | 64.97M | 58.70M | 57.55M | 34.68M |
| EPS Basic | 0.25 | 0.36 | 0.23 | -1.84 | 0.05 |
| Normalized Basic EPS | 0.26 | 0.38 | 0.33 | 0.29 | 0.12 |
| EPS Diluted | 0.24 | 0.36 | 0.23 | -1.84 | 0.05 |
| Normalized Diluted EPS | 0.25 | 0.38 | 0.32 | 0.29 | 0.12 |
| Average Basic Shares Outstanding | 84.44M | 85.16M | 83.89M | 83.33M | 82.86M |
| Average Diluted Shares Outstanding | 85.43M | 85.16M | 84.52M | 83.33M | 83.28M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |